Latest Novakand Pharma News & Updates

See the latest news and media coverage for Novakand Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Novakand Pharma

Developer of innovative drugs for inflammation and cancer

novakand.com
Company type
Public company
Number of employees
2–10

Last updated

Latest news about Novakand Pharma

In short: Novakand Pharma faced delisting from First North, canceled a merger with SVF Vaccines, and shifted focus back to its fractalkine program in 2026.

Company announcements

Novakand Pharma

Novakand Pharma calls for annual general meeting

The annual general meeting is held on May 25, 2026 in Stockholm. Registration is required by May 19. Agenda includes annual report, discharge from liability and elections.

Novakand Pharma

Novakand Pharma holds extraordinary general meeting

The meeting decides on focus on fractal kinase program, capital needs and special review of CEO, board and capital usage. The board makes seats available.

Unlock all announcements with a

Media coverage

Kauppalehti

Karolinska Development’s portfolio company SVF Vaccines and Novakand Pharma enters into a reverse acquisition agreement

STOCKHOLM, Sweden, February 6, 2026. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines has entered into a reverse acquisition agreement...

Unlock all articles with a

Never miss news about Novakand Pharma

Track Novakand Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Novakand Pharma competitors & trending companies

Browse news for competitors to Novakand Pharma and other trending companies.